title: Identification of cleavage sites leading to the shed form of the anti-aging protein klotho.
abstract: Membrane protein shedding is a critical step in many normal and pathological processes. The anti-aging protein klotho (KL), mainly expressed in kidney and brain, is secreted into the serum and CSF, respectively. KL is proteolytically released, or shed, from the cell surface by ADAM10 and ADAM17, which are the α-secretases that also cleave the amyloid precursor protein and other proteins. The transmembrane KL is a coreceptor with the FGF receptor for FGF23, whereas the shed form acts as a circulating hormone. However, the precise cleavage sites in KL are unknown. KL contains two major cleavage sites: one close to the juxtamembrane region and another between the KL1 and KL2 domains. We identified the cleavage site involved in KL release by mutating potential sheddase(s) recognition sequences and examining the production of the KL extracellular fragments in transfected COS-7 cells. Deletion of amino acids T958 and L959 results in a 50-60% reduction in KL shedding, and an additional P954E mutation results in further reduction of KL shedding by 70-80%. Deletion of amino acids 954-962 resulted in a 94% reduction in KL shedding. This mutant also had moderately decreased cell surface expression, yet had overall similar subcellular localization as that of WT KL, as demonstrated by immunofluorescence. Cleavage-resistant mutants could function as a FGFR coreceptor for FGF23, but they lost activity as a soluble form of KL in proliferation and transcriptional reporter assays. Cleavage between the KL1 and KL2 domains is dependent on juxtamembrane cleavage. Our results shed light onto mechanisms underlying KL release from the cell membrane and provide a target for potential pharmacologic interventions aimed at regulating KL secretion.
authors.affiliation: Departments of Biochemistry, ‡Biology, and §Pharmacology and Experimental Therapeutics, Boston University School of Medicine , Boston, Massachusetts 02118, United States.
authors.forename: Ci-Di
authors.initials: CD
authors.lastname: Chen
authors.forename: Tze Yu
authors.initials: TY
authors.lastname: Tung
authors.forename: Jennifer
authors.initials: J
authors.lastname: Liang
authors.forename: Ella
authors.initials: E
authors.lastname: Zeldich
authors.forename: Tracey B
authors.initials: TB
authors.lastname: Tucker Zhou
authors.forename: Benjamin E
authors.initials: BE
authors.lastname: Turk
authors.forename: Carmela R
authors.initials: CR
authors.lastname: Abraham
mesh_terms: D000595:Amino Acid Sequence; D001483:Base Sequence; D001665:Binding Sites; D017931:DNA Primers; D005966:Glucuronidase / Q000737:chemistry / Q000235:genetics / Q000378:metabolism*; D000090265:Klotho Proteins; D008969:Molecular Sequence Data; D016297:Mutagenesis, Site-Directed; D013347:Subcellular Fractions / Q000378:metabolism
chemical_list: D017931:DNA Primers; D005966:Glucuronidase; D000090265:Klotho Proteins
references.citation: Cell. 1997 Aug 22;90(4):589-92
references.pmid: 9288739
references.citation: BMC Nephrol. 2012 Nov 23;13:155
references.pmid: 23176706
references.citation: Curr Opin Cell Biol. 1998 Oct;10(5):654-9
references.pmid: 9818177
references.citation: Clin Cancer Res. 2011 Jul 1;17(13):4254-66
references.pmid: 21571866
references.citation: FEBS Lett. 2009 Oct 6;583(19):3221-4
references.pmid: 19737556
references.citation: Annu Rev Physiol. 2013;75:503-33
references.pmid: 23398153
references.citation: Glia. 2008 Jan 1;56(1):106-17
references.pmid: 17963266
references.citation: J Cell Sci. 1999 Nov;112 ( Pt 21):3603-17
references.pmid: 10523497
references.citation: Biochem Biophys Res Commun. 2000 Jan 19;267(2):597-602
references.pmid: 10631108
references.citation: Biochem J. 2012 Jan 1;441(1):453-61
references.pmid: 21939436
references.citation: J Biol Chem. 2002 Dec 27;277(52):50510-9
references.pmid: 12403792
references.citation: Adv Exp Med Biol. 2012;728:25-40
references.pmid: 22396160
references.citation: Science. 2005 Oct 21;310(5747):490-3
references.pmid: 16239475
references.citation: Science. 2005 Sep 16;309(5742):1829-33
references.pmid: 16123266
references.citation: J Neurosci. 2013 Jan 30;33(5):1927-39
references.pmid: 23365232
references.citation: Mol Biol Cell. 2009 Mar;20(6):1785-94
references.pmid: 19158376
references.citation: Biochem J. 2009 Oct 23;424(1):79-88
references.pmid: 19715556
references.citation: Cell. 2001 Oct 19;107(2):173-82
references.pmid: 11672525
references.citation: J Mol Neurosci. 2015 Jan;55(1):76-90
references.pmid: 24907942
references.citation: Age (Dordr). 2012 Dec;34(6):1405-19
references.pmid: 21922250
references.citation: J Biol Chem. 2013 Dec 20;288(51):36302-11
references.pmid: 24217253
references.citation: Oncogene. 2008 Nov 27;27(56):7094-105
references.pmid: 18762812
references.citation: Genes Dev. 2003 Jan 1;17(1):7-30
references.pmid: 12514095
references.citation: Curr Alzheimer Res. 2007 Sep;4(4):412-7
references.pmid: 17908044
references.citation: FEBS Lett. 2004 May 7;565(1-3):143-7
references.pmid: 15135068
references.citation: Pflugers Arch. 2010 Jan;459(2):333-43
references.pmid: 19730882
references.citation: EMBO J. 2003 Mar 3;22(5):1114-24
references.pmid: 12606576
references.citation: J Biol Chem. 2004 Jun 4;279(23):24179-88
references.pmid: 15066986
references.citation: Essays Biochem. 2002;38:141-53
references.pmid: 12463167
references.citation: Science. 1998 Nov 13;282(5392):1281-4
references.pmid: 9812885
references.citation: Genome Res. 2004 Jun;14(6):1188-90
references.pmid: 15173120
references.citation: Proc Natl Acad Sci U S A. 2007 Dec 11;104(50):19796-801
references.pmid: 18056631
references.citation: J Biol Chem. 2006 Mar 10;281(10):6120-3
references.pmid: 16436388
references.citation: Mol Pharmacol. 2009 Jul;76(1):38-46
references.pmid: 19349416
references.citation: Nat Clin Pract Rheumatol. 2008 Jun;4(6):300-9
references.pmid: 18414459
references.citation: Nature. 1997 Nov 6;390(6655):45-51
references.pmid: 9363890
references.citation: Comb Chem High Throughput Screen. 2005 Jun;8(4):327-39
references.pmid: 16101009